4.5 Article

Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Anti-CD34 Antibodies Immobilized on the Surface of Sirolimus-Eluting Stents Enhance Stent Endothelialization

Gaku Nakazawa et al.

JACC-CARDIOVASCULAR INTERVENTIONS (2010)

Review Cardiac & Cardiovascular Systems

Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk

Michael Joner et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)

Article Biotechnology & Applied Microbiology

Gene-eluting stents:: Comparison of adenoviral and adeno-associated viral gene delivery to the blood vessel wall in vivo

Faisal Sharif et al.

HUMAN GENE THERAPY (2006)

Article Multidisciplinary Sciences

Bisphosphonate-mediated gene vector delivery from the metal surfaces ot stents

I Fishbein et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Review Cardiac & Cardiovascular Systems

Drug-eluting stents: caution and concerns for long-term outcome

R Virmani et al.

CORONARY ARTERY DISEASE (2004)

Article Cardiac & Cardiovascular Systems

Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model

AJ Carter et al.

CARDIOVASCULAR RESEARCH (2004)

Article Cardiac & Cardiovascular Systems

Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model

T Suzuki et al.

CIRCULATION (2001)